Henry Schein, Inc.
The world's largest distributor of dental and medical supplies to office-based practitioners, headquartered in Melville, New York.
Company Type
public
Founded
1932
Headquarters
Melville, New York, USA
Stock
Nasdaq: HSIC
Revenue
Approximately $12.7 billion (FY2025)
Employees
Approximately 25,000
Primary Market
Global
Henry Schein, Inc. Timeline
Shop Henry Schein, Inc. Brands
Disclosure: We may earn commission from purchases
About Henry Schein, Inc.
What does Henry Schein own?
Henry Schein owns its dental, medical, and technology distribution operations, private-label product brands, and the Henry Schein One practice software venture.
Is Henry Schein publicly traded?
Yes. It trades on the Nasdaq under ticker HSIC.
Who founded Henry Schein?
Henry Schein, a pharmacist who opened a Queens, New York store in 1932.
Who is the CEO of Henry Schein?
Stanley Bergman, CEO since 1989, one of the longest-serving public company chiefs.
What does Henry Schein sell?
Dental and medical consumables, equipment, vaccines, and practice software to office-based practitioners.
How much revenue does Henry Schein generate?
Approximately $12.7 billion annually.
Where is Henry Schein headquartered?
Melville, New York, USA, on Long Island.
History of Henry Schein, Inc.
Henry Schein, a pharmacist, opened his Queens, New York drugstore in 1932, building a business supplying dental and medical products to local practitioners.
The company grew methodically through the postwar decades as a regional distributor before transforming under Stanley Bergman's leadership beginning in the 1980s, going public in 1995 and consolidating the fragmented dental and medical distribution industry through hundreds of acquisitions.
The expansion ran global through the 2000s, adding European and Asian operations and building the medical and technology arms alongside the dental core.
The company's software strategy consolidated into Henry Schein One, a technology joint venture formed to combine its practice-management assets with a partner's engineering strength, giving it a position in the software running dental offices.
Henry Schein, Inc. Sustainability & Ethics
The company publishes ESG reporting covering its global distribution footprint, workforce diversity, and community health programs.
Cold-chain vaccine distribution and supply-chain integrity are the operationally material standards it manages.
Controversy, Regulation & Public Scrutiny
Pricing and competition: The dental supply oligopoly has drawn periodic attention on pricing transparency from practitioners and regulators.
No major controversies define its public record beyond routine industry litigation.
Brands Owned by Henry Schein, Inc.
Henry Schein, Inc. owns 2 brands in our database. Explore the ownership tree below — click categories to expand and see individual brands.
Henry Schein, Inc.
public · Founded 1932 · Melville, New York, USA
2
brands
Stock Information
Henry Schein, Inc. Ownership: Pros & Cons
Advantages
- +Category-leading position in office-based distribution
- +Defensive demand: dental and medical consumables are non-discretionary
- +Four decades of acquisition-driven consolidation executed well
- +Software layer adds recurring revenue
- +Long-tenured CEO provides unusual strategic continuity
Considerations
- -Thin distribution margins cap profitability
- -Amazon and direct manufacturers pressure the model
- -Customer consolidation into dental service organizations shifts buying power
- -CEO succession is an open question after 35-plus years
- -Currency exposure across 30-plus countries
Frequently Asked Questions About Henry Schein, Inc.
What does Henry Schein own?
Henry Schein owns its dental, medical, and technology distribution operations, private-label product brands, and the Henry Schein One practice software venture.
Is Henry Schein publicly traded?
Yes. It trades on the Nasdaq under ticker HSIC.
Who founded Henry Schein?
Henry Schein, a pharmacist who opened a Queens, New York store in 1932.
Who is the CEO of Henry Schein?
Stanley Bergman, CEO since 1989, one of the longest-serving public company chiefs.
What does Henry Schein sell?
Dental and medical consumables, equipment, vaccines, and practice software to office-based practitioners.
How much revenue does Henry Schein generate?
Approximately $12.7 billion annually.
Where is Henry Schein headquartered?
Melville, New York, USA, on Long Island.
Sources & Further Reading
Jobs at Henry Schein, Inc.
Latest News About Henry Schein, Inc.
Related Articles About Henry Schein, Inc.
View more articles
Monthly IPO Roundup: November 2026 -- October's Biggest Listings
October 2026 IPOs: Jio Platforms set India's all-time record at $3.2B and surged 27%, GCash owner Mynt raised a Philippine-record P60.9B, Anthropic filed publicly for a possible mid-November debut, and U.S. listings were a biotech grab bag. Full recap.
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Duracell vs Energizer: The Battery Brand Rivalry
Duracell is Berkshire Hathaway-owned (25-30% US share). Energizer is publicly traded (NYSE: ENR) with Rayovac. Together they control ~85% of branded US batteries, but Amazon Basics has 27.1% online. Explore our database.
Related Companies to Henry Schein, Inc.
View more companies
Cognizant Technology Solutions Corporation
American multinational IT services and consulting company serving health sciences, financial services, products, and communications clients, with 2025 revenue of $21.1 billion.
2 brands in portfolio
Adobe Inc.
American multinational computer software company specializing in creativity, digital marketing, and document management software and services.
9 brands in portfolio
Automatic Data Processing, Inc.
World's largest payroll and human capital management company, paying roughly one in six U.S. workers, with fiscal 2025 revenue of $20.6 billion and 50 consecutive annual dividend increases.
1 brand in portfolio
Advanced Micro Devices Inc.
American multinational semiconductor company designing CPUs, GPUs, and adaptive computing solutions for data center, client, gaming, and embedded markets.
5 brands in portfolio
Amgen Inc.
American biotechnology company headquartered in Thousand Oaks, California, the world's largest independent biotech, producing Enbrel, Prolia, Otezla, and other medicines.
5 brands in portfolio
Applied Materials, Inc.
American semiconductor equipment maker supplying the machines, software, and services used to fabricate chips and displays in fabs worldwide.
1 brand in portfolio